Biphasic response of complement to heparin: Fluid-phase generation of neoantigens in human serum and in a reconstituted alternative pathway amplification cycle
- 1 December 1995
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 50 (4) , 254-262
- https://doi.org/10.1002/ajh.2830500406
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Identification of multiple sites of interaction between heparin and the complement systemMolecular Immunology, 1993
- In vitro Formation of Complement Activation Products by Lipopolysaccharide Chemotypes of SalmonellaminnesotaInternational Archives of Allergy and Immunology, 1991
- Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Proceedings of the National Academy of Sciences, 1990
- Potentiation of factor H by heparin: A rate-limiting mechanism for inhibition of the alternative complement pathwayMolecular Immunology, 1983
- A postulated mechanism for heparin's potentiation of C1 inhibitor functionMolecular Immunology, 1982
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.The Journal of Experimental Medicine, 1979
- Mode of interaction of different polyanions with the first (C1, C), the second (C2) and the fourth (C4) component of complement-III: Inhibition of C4 and C2 binding site(s) on C1s̄ by polyanionsImmunochemistry, 1976
- Mode of interaction of different polyanions with the first (), the second (C2) and the fourth (C4) component of complement—II: Effect of polyanions on the binding of C2 to EAC4bImmunochemistry, 1976
- Mode of interaction of different polyanions with the first () the second (C2) and the fourth (C4) component of complement—I: Effect on fluid phase and on bound toEA or to EAC4Immunochemistry, 1976